The purpose of the WARFARIN Study is to determine the utility of genetic testing in reducing the incidence of adverse events, both bleeding and thromboembolism, associated with the initiation of warfarin therapy.
Copyright 2011 Iverson Genetic Diagnostics, Inc. All Rights Reserved.
